Medical education and health for all.

Medical education and health for all: dream, mirage or nemesis? Aust J Public Health (1995) 0.75

Medical education and health for all. Aust N Z J Public Health (1996) 0.75

Medical education at the University of Sydney. Aust J Public Health (1995) 0.75

Kidney transplantation under FK 506. JAMA (1990) 7.45

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Nucleic acid reactivity and conformation. II. Reaction of cytosine and uracil with sodium bisulfite. J Biol Chem (1973) 4.44

X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet (2001) 3.86

The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors. Nat Med (2001) 3.85

The impact of conversion from prograf to generic tacrolimus in liver and kidney transplant recipients with stable graft function. Am J Transplant (2011) 3.42

Deamination of cytosine derivatives by bisulfite. Mechanism of the reaction. J Am Chem Soc (1974) 2.92

Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer. Ann Oncol (2013) 2.51

FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation (1994) 2.50

Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. Am J Transplant (2006) 2.48

The deamination of cytidine and cytosine by acidic buffer solutions. Mutagenic implications. Biochemistry (1966) 2.30

Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J (1999) 2.28

On the reaction of guanine with glyoxal, pyruvaldehyde, and kethoxal, and the structure of the acylguanines. A new synthesis of N2-alkylguanines. Biochemistry (1969) 2.25

Overview: deinstitutionalization of psychiatric patients, a critical review of outcome studies. Am J Psychiatry (1981) 2.24

Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level? Am J Transplant (2015) 2.24

A critical appraisal of methods to grade transplant glomerulitis in renal allograft biopsies. Am J Transplant (2010) 2.14

Characteristic ribonucleolytic activity of human angiogenin. Biochemistry (1986) 2.06

Quantifying the risk of incompatible kidney transplantation: a multicenter study. Am J Transplant (2014) 2.00

Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation (1999) 1.93

The point system for organ distribution. Transplant Proc (1989) 1.88

Experience with liver and kidney allografts from non-heart-beating donors. Transplantation (1995) 1.83

Molecular recognition of human angiogenin by placental ribonuclease inhibitor--an X-ray crystallographic study at 2.0 A resolution. EMBO J (1997) 1.77

Specific acylation of the guanine residues of ribonucleic acid. J Biol Chem (1970) 1.74

Cryoablation of unresectable malignant liver tumors. Am J Surg (1996) 1.62

Donor-transmitted malignancies in organ transplantation: assessment of clinical risk. Am J Transplant (2011) 1.59

Inhibition of HIV infection by a novel CD4 domain 2-specific monoclonal antibody. Dissecting the basis for its inhibitory effect on HIV-induced cell fusion. J Immunol (1992) 1.58

The 'two, one, zero' decision: what to do with suboptimal deceased donor kidneys. Am J Transplant (2010) 1.58

Tight-binding inhibition of angiogenin and ribonuclease A by placental ribonuclease inhibitor. Biochemistry (1989) 1.57

Sites of nonenzymatic glycosylation of human hemoglobin A. J Biol Chem (1980) 1.56

New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients. Transplant Proc (1991) 1.56

Regular articles: conditional disruption of hedgehog signaling pathway defines its critical role in hair development and regeneration. J Invest Dermatol (2000) 1.56

Comparison of FK-506 and cyclosporine regimens in pediatric renal transplantation. Pediatr Nephrol (1994) 1.55

Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin. Proc Natl Acad Sci U S A (1987) 1.55

Acidic hydrolysis of deoxycytidine and deoxyuridine derivatives. The general mechanism of deoxyribonucleoside hydrolysis. Biochemistry (1972) 1.54

Nosocomial outbreak of tuberculosis in a renal transplant unit: application of a new technique for restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates. J Infect Dis (1993) 1.53

Posterior reversible encephalopathy syndrome after solid organ transplantation. AJNR Am J Neuroradiol (2008) 1.53

Bisulfite-catalyzed transamination of cytosine and cytidine. Biochem Biophys Res Commun (1970) 1.52

Isolation and identification of cross-links from formaldehyde-treated nucleic acids. Biochemistry (1980) 1.52

Ethical considerations for participation of nondirected living donors in kidney exchange programs. Am J Transplant (2010) 1.51

The reaction of guanine derivatives with 1,2-dicarbonyl compounds. Biochemistry (1966) 1.50

Uncatalyzed hydrolysis of deoxyuridine, thymidine, and 5-bromodeoxyuridine. Biochemistry (1969) 1.49

Pancreas transplantation with enteric drainage under tacrolimus induction therapy. Transplant Proc (1997) 1.48

The mutagenic specificity of sodium bisulfite. Biochem Biophys Res Commun (1970) 1.48

Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers. Am J Pathol (1988) 1.45

Crystal structure of the superantigen enterotoxin C2 from Staphylococcus aureus reveals a zinc-binding site. Structure (1995) 1.42

Adverse effects associated with the use of FK 506. Transplant Proc (1991) 1.41

Ciprofloxacin does not block the antiproliferative effect of tacrolimus. Transplantation (1997) 1.39

Mechanism of obstruction of the infradiaphragmatic portion of the inferior vena cava in the presence of increased intra-abdominal pressure. Invest Radiol (1966) 1.39

FK 506 conversion of renal allografts failing cyclosporine immunosuppression. Transplant Proc (1991) 1.37

Diffuse skeletal abnormalities in Forestier disease. Arch Intern Med (1976) 1.37

Embryogenesis of the human occipital bone. AJR Am J Roentgenol (1976) 1.36

Contribution of naïve and memory T-cell populations to the human alloimmune response. Am J Transplant (2009) 1.34

The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine. Am J Surg Pathol (1993) 1.32

Two-year follow-up of the patients included in the WHO International Pilot Study of Schizophrenia. Psychol Med (1977) 1.32

Indomethacin-induced prostaglandin inhibition with hyperkalemia. A reversible cause of hyporeninemic hypoaldosteronism. Ann Intern Med (1979) 1.30

Structural heterogeneity of human hemoglobin A due to nonenzymatic glycosylation. J Biol Chem (1979) 1.30

Crystal structure of human angiogenin reveals the structural basis for its functional divergence from ribonuclease. Proc Natl Acad Sci U S A (1994) 1.30

Dual site model for the organogenic activity of angiogenin. Proc Natl Acad Sci U S A (1991) 1.29

BK virus infection in a kidney allograft diagnosed by needle biopsy. Am J Kidney Dis (1995) 1.28

The Danish twin register. Acta Genet Med Gemellol (Roma) (1968) 1.25

Leukotriene A4 hydrolase: determination of the three zinc-binding ligands by site-directed mutagenesis and zinc analysis. Proc Natl Acad Sci U S A (1991) 1.25

Pseudomonas folliculitis. Development after the home use of personal whirlpool spa. Cutis (1980) 1.24

Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol (1996) 1.24

Ovarian carcinomatosis presenting with hyperamylasemia and pleural effusion. Am J Gastroenterol (1981) 1.24

Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients. Ann Surg (1999) 1.24

Isolation and characterization of a human colon carcinoma-secreted enzyme with pancreatic ribonuclease-like activity. Biochemistry (1986) 1.24

Augmentation of chimerism in whole organ recipients by simultaneous infusion of donor bone marrow cells. Transplant Proc (1995) 1.24

The effect of legislative requirements on the use of breast-conserving surgery. N Engl J Med (1996) 1.24

Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates. Am J Transplant (2013) 1.22

Recipient tissue factor expression is associated with consumptive coagulopathy in pig-to-primate kidney xenotransplantation. Am J Transplant (2010) 1.21

Fine-needle aspiration biopsy in pancreatic transplantation. Transplant Proc (1995) 1.21

The reaction of ribonucleosides with nitrous acid. Side products and kinetics. Biochemistry (1968) 1.20

Glycosylated minor components of human adult hemoglobin. Purification, identification, and partial structural analysis. J Biol Chem (1978) 1.20

Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation. Am J Gastroenterol (2000) 1.19

Immune status of recipients following bone marrow-augmented solid organ transplantation. Transplantation (1995) 1.18

Role of glutamine-117 in the ribonucleolytic activity of human angiogenin. Proc Natl Acad Sci U S A (1994) 1.17

Effect of mechanical ventilation strategy on dissemination of intratracheally instilled Escherichia coli in dogs. Crit Care Med (1997) 1.16

Analysis of clinical variation seen in patients with 18q terminal deletions. Am J Med Genet (1995) 1.16

Extraosseous extension of Gaucher cell deposits mimicking malignancy. Skeletal Radiol (1994) 1.16

High-level expression of three members of the murine angiogenin family in Escherichia coli and purification of the recombinant proteins. Protein Expr Purif (2001) 1.15

Treatment of haemangioendotheliomas with alpha interferon. Lancet (1989) 1.15

Genetic effects of bisulfite (sulfur dioxide). Mutat Res (1977) 1.14

Alteration of the enzymatic specificity of human angiogenin by site-directed mutagenesis. Biochemistry (1993) 1.14

Importance of asparagine-61 and asparagine-109 to the angiogenic activity of human angiogenin. Biochemistry (1992) 1.13

Specific deamination of RNA by sodium bisulphite. Nature (1970) 1.13

Computed tomography of temporal bone pneumatization: 1. Normal pattern and morphology. AJR Am J Roentgenol (1985) 1.13

Cyclosporin for severe ulcerative colitis. Isr Med Assoc J (2000) 1.12

The hepatocyte as a microbial product-responsive cell. J Endotoxin Res (2001) 1.10

Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease. Clin Exp Immunol (2015) 1.10

longitudinal analysis of levels of immunoglobulins against BK virus capsid proteins in kidney transplant recipients. Clin Vaccine Immunol (2008) 1.09

Reactions of cytosine derivatives with acidic buffer solutions. II. Studies on transamination, deamination, and deuterium exchange. Biochemistry (1967) 1.08

WHO international pilot study of schizophrenia. Psychol Med (1972) 1.08

Augmentation of chimerism with perioperative donor bone marrow infusion in organ transplant recipients: a 44 month follow-up. Transplant Proc (1997) 1.07

Leukotriene A4 hydrolase: abrogation of the peptidase activity by mutation of glutamic acid-296. Proc Natl Acad Sci U S A (1992) 1.07

Leukotriene A4 hydrolase: a zinc metalloenzyme. Biochem Biophys Res Commun (1990) 1.06

The radiologist and the problem of renal vascular hypertension. Am J Roentgenol Radium Ther Nucl Med (1965) 1.06

Biopsy of marginal donor kidneys: correlation of histologic findings with graft dysfunction. Transplantation (2000) 1.05

Refined crystal structures of native human angiogenin and two active site variants: implications for the unique functional properties of an enzyme involved in neovascularisation during tumour growth. J Mol Biol (1999) 1.05

Dissociation of depletional induction and posttransplant lymphoproliferative disease in kidney recipients treated with alemtuzumab. Am J Transplant (2007) 1.04

Epstein-Barr virus--determined clonality in posttransplant lymphoproliferative disease. Transplantation (1990) 1.04